Recent progresses in biomedical applications of aptamer-functionalized systems

Bioorg Med Chem Lett. 2017 Sep 15;27(18):4256-4269. doi: 10.1016/j.bmcl.2017.03.032. Epub 2017 Mar 18.

Abstract

Aptamers, known as "chemical antibodies" are screened via a combinational technology of systematic evolution of ligands by exponential enrichment (SELEX). Due to their specific targeting ability, high binding affinity, low immunogenicity and easy modification, aptamer-functionalized systems have been extensively applied in various fields and exhibit favorable results. However, there is still a long way for them to be commercialized, and few aptamer-functionalized systems have yet successfully entered clinical and industrial use. Thus, it is necessary to overview the recent research progresses of aptamer-functionalized systems for the researchers to improve or design novel and better aptamer-functionalized systems. In this review, we first introduce the recent progresses of aptamer-functionalized systems' applications in biosensing, targeted drug delivery, gene therapy and cancer cell imaging, followed by a discussion of the challenges faced with extensive applications of aptamer-functionalized systems and speculation of the future prospects of them.

Keywords: Aptamer; Aptamer-functionalized systems; Biosensing; Cancer cell imaging; Gene therapy; Targeted drug delivery.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aptamers, Nucleotide / chemistry*
  • Biomedical Research*
  • Biosensing Techniques
  • Drug Delivery Systems
  • Genetic Therapy
  • Humans
  • Neoplasms / diagnosis*

Substances

  • Aptamers, Nucleotide